The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations
Open accessAbstract
Laparoscopic surgery is the main treatment method for patients with gastrointestinal malignant tumors. Although laparoscopic surgery is minimally invasive, its tool stimulation and pneumoperitoneum pressure often cause strong stress reactions in patients. On the other hand, gastrointestinal surgery can cause stronger pain in patients, compared to other surgeries. Transversus abdominis plane block (TAPB) can effectively inhibit the transmission of nerve impulses caused by surgical stimulation, alleviate patient pain, and thus alleviate stress reactions. Remazolam is an acting, safe, and effective sedative, which has little effect on hemodynamics and is suitable for most patients. TAPB combined with remazolam can reduce the dosage of total anesthetic drugs, reduce adverse reactions, reduce stress reactions, and facilitate the rapid postoperative recovery of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · PubMed · Cited by 13,173
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Years of Life Lost Due to Obesity
Fontaine, K. R., Redden, D. T., Wang, C., Westfall, A. O., & Allison, D. B. (2003) · JAMA · doi:10.1001/jama.289.2.187 · Cited by 2,495
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,296
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Postic, C., & Girard, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34275 · Cited by 1,204
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049
Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
The interaction of hepatic lipid and glucose metabolism in liver diseases
Bechmann, L. P., Hannivoort, R. A., Gerken, G., Hotamisligil, G. S., Trauner, M., & Canbay, A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.025 · Cited by 994
Tomas, E., Tsao, T.-S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., Lodish, H. F., & Ruderman, N. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222657499 · Cited by 973
Splanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933
Morino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853
Life without white fat: a transgenic mouse
Moitra, J., Mason, M. M., Olive, M., Krylov, D., Gavrilova, O., Marcus-Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., et al. (1998) · Genes & Development · doi:10.1101/gad.12.20.3168 · Cited by 782
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766
Endpoints and clinical trial design for nonalcoholic steatohepatitis
Sanyal, A. J., Brunt, E. M., Kleiner, D. E., Kowdley, K. V., Chalasani, N., Lavine, J. E., Ratziu, V., & McCullough, A. (2011) · Hepatology · doi:10.1002/hep.24376 · Cited by 750
Intestinal microbiota in patients with nonalcoholic fatty liver disease
Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749
Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
Dasarathy, S., Dasarathy, J., Khiyami, A., Joseph, R., Lopez, R., & McCullough, A. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.09.001 · Cited by 656
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604
The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence
Mantzoros, C. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-8-199904200-00014 · Cited by 584
Causes and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H.-U. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 532
Boden, G., She, P., Mozzoli, M., Cheung, P., Gumireddy, K., Reddy, P., Xiang, X., Luo, Z., & Ruderman, N. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3458 · Cited by 528
Ecological control of the gastrointestinal tract. The role of probiotic flora
BENGMARK, S. (1998) · Gut · doi:10.1136/gut.42.1.2 · Cited by 509
From the metabolic syndrome to NAFLD or vice versa?
Vanni, E., Bugianesi, E., Kotronen, A., De Minicis, S., Yki-Järvinen, H., & Svegliati-Baroni, G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.016 · Cited by 497
Schwarz, J.-M., Linfoot, P., Dare, D., & Aghajanian, K. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.43 · Cited by 496
Liver Fat in the Metabolic Syndrome
Kotronen, A., Westerbacka, J., Bergholm, R., Pietiläinen, K. H., & Yki-Järvinen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0482 · Cited by 457
Quehenberger, O., & Dennis, E. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1104901 · Cited by 454
Pessayre, D., & Fromenty, B. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.004 · Cited by 441
Bugianesi, E., Pagotto, U., Manini, R., Vanni, E., Gastaldelli, A., de Iasio, R., Gentilcore, E., Natale, S., Cassader, M., Rizzetto, M., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2240 · Cited by 408
Day, C. P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.017 · Cited by 395
Ueki, K., Kondo, T., Tseng, Y.-H., & Kahn, C. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402511101 · Cited by 384
Choi, C. S., Savage, D. B., Kulkarni, A., Yu, X. X., Liu, Z.-X., Morino, K., Kim, S., Distefano, A., Samuel, V. T., Neschen, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704213200 · Cited by 383
Chitturi, S., Farrell, G., Frost, L., Kriketos, A., Lin, R., Liddle, C., Samarasinghe, D., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.34738 · Cited by 362
Parks, E. J., Krauss, R. M., Christiansen, M. P., Neese, R. A., & Hellerstein, M. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6572 · Cited by 349
The morphology and metabolism of intraabdominal adipose tissue in men
Mårin, P., Andersson, B., Ottosson, M., Olbe, L., Chowdhury, B., Kvist, H., Holm, G., Sjöström, L., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90016-4 · Cited by 336
Liver pathology in morbidly obese patients with and without diabetes.
Silverman, J. F., O’Brien, K. F., Long, S., Leggett-Frazier, N., Khazanie, P. G., Pories, W. J., Norris, H. T., & F., J. (1990) · PubMed · Cited by 301
Non-alcoholic fatty liver disease pathogenesis: The present and the future
Petta, S., Muratore, C., & Craxì, A. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.01.004 · Cited by 285
Ortiz-Lopez, C., Lomonaco, R., Orsak, B., Finch, J., Chang, Z., Kochunov, V. G., Hardies, J., & Cusi, K. (2012) · Diabetes Care · doi:10.2337/dc11-1849 · Cited by 253
Adiponectin, a key adipokine in obesity related liver diseases.
Buechler, C., Wanninger, J., & Neumeier, M. (2011) · PubMed · doi:10.3748/wjg.v17.i23.2801 · Cited by 242
Body fat distribution, relative weight, and liver enzyme levels: A population-based study
Stranges, S., Dorn, J. M., Muti, P., Freudenheim, J. L., Farinaro, E., Russell, M., Nochajski, T. H., & Trevisan, M. (2004) · Hepatology · doi:10.1002/hep.20149 · Cited by 233
The Impact of Bariatric Surgery on Psychological Health
Kubik, J. F., Gill, R. S., Laffin, M., & Karmali, S. (2013) · Journal of Obesity · doi:10.1155/2013/837989 · Cited by 229
Obesity Affects the Liver – The Link between Adipocytes and Hepatocytes
Wree, A., Kahraman, A., Gerken, G., & Canbay, A. (2011) · Digestion · doi:10.1159/000318741 · Cited by 215
NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Franchini, M., Zoppini, G., Muggeo, M., & Day, C. P. (2008) · Obesity · doi:10.1038/oby.2008.64 · Cited by 214
Metabolic syndrome and risk factors for non-alcoholic fatty liver disease
Souza, M. R. D. A., Diniz, M. D. F. F. D. M., Medeiros-Filho, J. E. M. D., & Araújo, M. S. T. D. (2012) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032012000100015 · Cited by 213
Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics
Solga, S. F., & Diehl, A. M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00097-7 · Cited by 210
Kupffer cells mediate leptin-induced liver fibrosis
Wang, J., Leclercq, I., Brymora, J. M., Xu, N., Ramezani–Moghadam, M., London, R. M., Brigstock, D., & George, J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.011 · Cited by 210
Liver and diabetes. A vicious circle
Loria, P., Lonardo, A., & Anania, F. (2013) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01031.x · Cited by 208
Thematic review series: Patient-Oriented Research. Free fatty acid metabolism in human obesity
Koutsari, C., & Jensen, M. D. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600011-jlr200 · Cited by 198
Milić, S., & Štimac, D. (2012) · Digestive Diseases · doi:10.1159/000336669 · Cited by 192
Self-citationPagano, C., Soardo, G., Pilon, C., Milocco, C., Basan, L., Milan, G., Donnini, D., Faggian, D., Mussap, M., Plebani, M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1056 · Cited by 191
Marchesini, G., Avagnina, S., Barantani, E. G., Ciccarone, A. M., Corica, F., Dall’Aglio, E., Grave, R. D., Morpurgo, P. S., Tomasi, F., & Vitacolonna, E. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347199 · Cited by 170
The Metabolically Benign and Malignant Fatty Liver
Stefan, N., & Häring, H.-U. (2011) · Diabetes · doi:10.2337/db11-0231 · Cited by 169
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Ehehalt, R., Füllekrug, J., Pohl, J., Ring, A., Herrmann, T. R. W., & Stremmel, W. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9034-1 · Cited by 167
Adiponectin, a key adipokine in obesity related liver diseases
Christa, Buechler, Josef, Wanninger, Markus, M. L., & Neumeier (2011) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 167
Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways
Agarwal, A. K., & Garg, A. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00078-x · Cited by 165
Shimada, M., Kawahara, H., Ozaki, K., Fukura, M., Yano, H., Tsuchishima, M., Tsutsumi, M., & Takase, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01322.x · Cited by 163
Knebel, B., Haas, J., Hartwig, S., Jacob, S., Köllmer, C., Nitzgen, U., Muller–Wieland, D., & Kotzka, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031812 · Cited by 162
Endocrine and liver interaction: the role of endocrine pathways in NASH
Loria, P., Carulli, L., Bertolotti, M., & Lonardo, A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.33 · Cited by 161
Hafeez, S., & Ahmed, M. H. (2013) · Journal of Obesity · doi:10.1155/2013/839275 · Cited by 159
‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis
Lonardo, A., Carani, C., Carulli, N., & Loria, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.03.005 · Cited by 149
Mirza, M. S. (2011) · ISRN Gastroenterology · doi:10.5402/2011/592404 · Cited by 148
Kaplan, M. S., Huguet, N., Newsom, J. T., McFarland, B. H., & Lindsay, J. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.11.m1018 · Cited by 148
The expanding role of fish models in understanding non-alcoholic fatty liver disease
Asaoka, Y., Terai, S., Sakaida, I., & Nishina, H. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011981 · Cited by 144
Lonardo, A., Sookoian, S. C., Chonchol, M., Loria, P., & Targher, G. (2012) · Current Pharmaceutical Design · doi:10.2174/1381612811319290003 · Cited by 134
Gao, X., Fan, J., & Study Group of Liver and Metabolism, C. S. O. E. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12056 · Cited by 133
Yilmaz, Y. N., Yönal, O., Kurt, R., Alahdab, Y. Ö., Eren, F., Ozdogan, O. C., Çelikel, Ç., İmeryüz, N., Kalaycı, C., & Avşar, E. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.516452 · Cited by 130
Thamer, C., Tschritter, O., Haap, M., Shirkavand, F., Machann, J., Fritsche, A., Schick, F., Häring, H., & Stumvoll, M. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-861411 · Cited by 119
Hsiao, T.-J., Chen, J., & Wang, J.-D. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802519 · Cited by 115
Targher, G., Bertolini, L., Scala, L., Poli, F., Zenari, L., & Falezza, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02151.x · Cited by 110
Biddinger, S. B., Miyazaki, M., Boucher, J., Ntambi, J. M., & Kahn, C. R. (2006) · Diabetes · doi:10.2337/db05-0742 · Cited by 107
Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data
Mavrogiannaki, A. N., & Migdalis, I. N. (2013) · International Journal of Endocrinology · doi:10.1155/2013/450639 · Cited by 104
Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity
Mezey, E., Imbembo, A., Potter, J., Rent, K., Lombardo, R., & Holt, P. R. (1975) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/28.11.1277 · Cited by 102
Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease
Attar, B. M., & Thiel, D. H. V. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/481893 · Cited by 98
Parks, E. J., & Hellerstein, M. K. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600018-jlr200 · Cited by 85
Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
Aller, R., de Luis, D. A., Izaola, O., Sagrado, M. G., Conde, R., Velasco, M. C., Alvarez, T., Pacheco, D., & González, J. M. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0539-9 · Cited by 79
Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease
Huang, X., Fan, Y., Hen, Z., Wang, P., Yuan, J.-P., Li, M., & Zhan, X.-Y. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2888 · Cited by 78
Kim, L. J., Nalls, M. A., Eiríksdóttir, G., Sigurdsson, S. O., Launer, L. J., Koster, A., Chaves, P. H. M., Jónsdóttir, B., García, M., Gudnason, V. G., et al. (2010) · Obesity · doi:10.1038/oby.2010.291 · Cited by 71
Intrahepatic Lipids Are Predicted by Visceral Adipose Tissue Mass in Healthy Subjects
Thamer, C., Machann, J., Haap, M. M., Stefan, N., Heller, E., Schnödt, B., Stümvoll, M., Claussen, C. D., Fritsche, A., Schick, F., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2726 · Cited by 70
Vargas, V., Allende, H., Lecube, A., Salcedo, M. T., Baena-Fustegueras, J. A., Fort, J. M., Rivero, J., Ferrer, R., Catalán, R., Pardina, E., et al. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i12.382 · Cited by 69
Billiar, T. R., Maddaus, M. A., West, M. A., CURRAN, R. D., Wells, C., & Simmons, R. L. (1988) · Annals of Surgery · doi:10.1097/00000658-198810000-00015 · Cited by 60
Zoico, E. (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000302 · Cited by 59
Insulin Resistance Takes a Trip Through the ER
Muoio, D. M., & Newgard, C. B. (2004) · Science · doi:10.1126/science.1104680 · Cited by 46
Clinical physiology of NAFLD: a critical overview of pathogenesis and treatment
Lonardo, A., Caldwell, S. H., & Loria, P. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.5 · Cited by 25
Lonardo, A., Sookoian, S. C., Chonchol, M., Loria, P., & Targher, G. (2012) · Current Pharmaceutical Design · doi:10.2174/13816128130301 · Cited by 21
Fatty Liver: A Link to Cardiovascular Disease – Its Natural History, Pathogenesis, and Treatment
Monsour, H., Frenette, C. T., & Wyne, K. L. (2012) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-8-3-21 · Cited by 20
Cited by
Current status and future trends of the global burden of MASLD
Miao, L., Targher, G., Byrne, C. D., Cao, Y.-Y., & Zheng, M.-H. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.02.007 · Cited by 781
Non-alcoholic fatty liver disease and dyslipidemia: An update
Katsiki, N., Mikhailidis, D. P., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.003 · Cited by 564
Global patterns in excess body weight and the associated cancer burden
Sung, H., Siegel, R. L., Torre, L. A., Pearson‐Stuttard, J., Islami, F., Fedewa, S. A., Goding Sauer, A., Shuval, K., Gapstur, S. M., Jacobs, E. J., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21499 · Cited by 548
Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity
Hammarstedt, A., Gogg, S., Hedjazifar, S., Nerstedt, A., & Smith, U. (2018) · Physiological Reviews · doi:10.1152/physrev.00034.2017 · Cited by 462
Guo, X., Yin, X., Liu, Z., & Wang, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415489 · Cited by 412
Metadata
- Authors
- Milić, S.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014-07-28
- Volume
- 20
- Issue
- 28
- Pages
- 9330-9337
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2160517419
- Cited by
- 583
- References
- 103
- FWCI
- 15.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.